How is the Greenwich LifeSciences Inc today?

The Greenwich LifeSciences Inc today is trading in the down by -0.55% at 9.00.

How has Greenwich LifeSciences Inc performed historically?

The Greenwich LifeSciences Inc is currently trading down -0.55% on an intraday basis in the past week the index fell -0.33%. The index has been down -20.00% in the past quarter and fell -41.94% in the past year. You can view this in the overview section.

What is Greenwich LifeSciences Inc Annual Net Profit?

Greenwich LifeSciences Inc Annual Net Profit fell 77.57% in the last year to $15.79 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is Greenwich LifeSciences Inc Price to Earning Ratio?

Greenwich LifeSciences Inc Price to Earning Ratio is -7.26, which is negative.

What is Greenwich LifeSciences Inc Stock Price?

Greenwich LifeSciences Inc Stock Price fell 41.94% and underperformed its sector by 99.47% in the past year.

What is Greenwich LifeSciences Inc Quarterly Net profit?

Greenwich LifeSciences Inc Quarterly Net profit fell 31.75% YoY to $3.26 M. Its sector's average net profit growth YoY for the quarter was -236.04%.

What is Greenwich LifeSciences Inc Return on Equity(ROE)?

Greenwich LifeSciences Inc Return on Equity(ROE) for the last financial year was -341.95%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Greenwich LifeSciences Inc Mutual Fund Holding?

Greenwich LifeSciences Inc Mutual Fund Holding decreased by 0.29% in the last quarter to 9.04.

What is Greenwich LifeSciences Inc Institutional Holding?

Greenwich LifeSciences Inc Institutional Holding decreased by 0.13% in the last quarter to 8.85.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
GREENWICH LIFESCIENCES INC

Greenwich LifeSciences Inc XNAS: GLSI

Greenwich LifeSciences Inc Live Share Price Today, Share Analysis and Chart

Name: Greenwich LifeSciences Inc: Is Infosys Ltd. worth buying?
Item: Greenwich LifeSciences Inc
Rating: 0.72075
Author: Trendlyne DVM scores

about

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane pepti...

9.00 -0.05 (-0.55%)

50.41% Fall from 52W High

29,061

XNAS Volume

XNAS 25 Jun, 2025 4:01 PM (EDT)

Not Eligible

Expensive Valuation

0.5 / 100

Technically Bearish

28.3 / 100

No estimates available

Greenwich LifeSciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Greenwich LifeSciences Inc Live Share Price Today, Share Analysis and Chart

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane pepti...

50.41% Fall from 52W High

SWOT Analysis

Greenwich LifeSciences Inc Live Price Chart

Greenwich LifeSciences Inc FAQ

How is Greenwich LifeSciences Inc today?

Greenwich LifeSciences Inc today is trading in the red, and is down by -0.55% at 9.00.

How has Greenwich LifeSciences Inc performed historically?

Greenwich LifeSciences Inc is currently trading down -0.55% on an intraday basis. In the past week the stock fell -0.33%. stock has been down -20.00% in the past quarter and fell -41.94% in the past year. You can view this in the overview section.